Friday 6 November 2026
Export LH’s income statement to Excel — free account
Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.
- Revenue
- +6.92%
- EPS
- +3.18%
- Free cash flow
- +44.7%
- Total debt
- +3.21%
Quarter to September 2026, against a year earlier
364.14
0.84
+0.23%
Follow LH
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 8 | 7 | 8 |
+8 more TTM periods Free account |
| 11.45% | 11.74% | 11.05% | 10.51% | ||
| 5.40% | 5.48% | 5.13% | 4.77% | ||
ROIC |
6.76% | 6.50% | 6.59% | 6.54% | |
Return on Tangible Assets |
23.41% | 20.92% | 18.89% | 20.49% | |
Average Days of Receivables |
63.99 | 63.72 | 63.24 | 59.14 | |
Free Cash Flow per Share |
15.97 | 14.33 | 17.00 | 14.59 | |
Free Cash Flow |
1,294.90 | 1,170.50 | 1,399.30 | 1,214.00 | |
Capital Expenditures |
(520.10) | (467.90) | (414.20) | (426.50) | |
| Other line items | |||||
Cash ROIC |
8.98% | 7.98% | 8.97% | 8.49% | |
Accounts Receivable Turnover |
6.05 | 6.00 | 5.99 | 6.40 | |
Accounts Payable Turnover |
14.74 | 13.78 | 14.24 | 11.58 | |
Inventory Turnover |
19.56 | 19.07 | 20.42 | 19.34 | |
Average Days of Payables |
25.98 | 24.63 | 25.23 | 30.88 | |
Days of Inventory on Hand |
18.96 | 20.11 | 18.05 | 19.64 | |
Tax Rate |
(0.18) | (0.19) | (0.18) | (0.21) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.61% | 15.47% | 15.70% | 15.89% | |
Share Based Compensation of Revenue |
0.87% | 0.87% | 0.88% | 0.90% | |
Interest Coverage |
6.52 | 6.59 | 6.45 | 6.18 | |
Operating CF/Net income |
1.81 | 1.63 | 1.93 | 1.87 | |
Depreciation/Fixed assets |
0.22 | 0.22 | 0.22 | 0.22 | |
Capex/Depreciation |
(0.74) | (0.67) | (0.60) | (0.63) | |
Revenue per Share |
179.96 | 175.62 | 171.86 | 167.69 | |
Operating CF per Share |
22.38 | 20.05 | 22.04 | 19.72 | |
Capex per Share |
(6.41) | (5.73) | (5.03) | (5.13) | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026